Search results
Results From The WOW.Com Content Network
In medicine, photopheresis (aka extracorporeal photopheresis or ECP) [1] is a form of apheresis and photodynamic therapy in which blood is subject to apheresis to separate buffy coat (WBC + platelets) from whole blood, chemically treated with 8-methoxypsoralen (instilled into a collection bag or given per os in advance), exposed to ultraviolet light (UVA), and then returned to the patient. [2]
Photopheresis – used to treat graft-versus-host disease, cutaneous T-cell lymphoma, and rejection in heart transplantation. Immunoadsorbtion with Staphylococcal protein A -agarose column – removal of allo- and autoantibodies (in autoimmune diseases, transplant rejection, hemophilia) by directing plasma through protein A-agarose columns.
The applications of photophoresis expand into the various divisions of science, thus physics, chemistry as well as in biology. Photophoresis is applied in particle trapping and levitation, [3] in the field flow fractionation of particles, [4] in the determination of thermal conductivity and temperature of microscopic grains [5] and also in the transport of soot particles in the atmosphere. [6]
Endoscopic CycloPhotocoagulation, a minimally invasive treatment for the management of glaucoma; Extracorporeal photopheresis, a therapy in which blood is treated with a photosensitizing agent and subsequently irradiated with light; External counterpulsation, a non-invasive therapy used to treat chronic angina and other ischemic heart diseases
Erythrocytapheresis is an apheresis procedure by which erythrocytes (red blood cells) are separated from whole blood.It is an extracorporeal blood separation method whereby whole blood is extracted from a donor or patient, the red blood cells are separated, and the remaining blood is returned to circulation.
This research led to his founding of the company TransImmune AG. He also performed research into the use of photopheresis in cancer treatment, [8] using ultraviolet light. His experiments included partnering with Columbia, the University of California at San Francisco, and the universities of Düsseldorf, Vienna and Pennsylvania.
An increasing number of recent treatment options for SR-GVHD have been investigated, such as extracorporeal photopheresis (ECP), mesenchymal stem cell (MSCs), fecal microbial transplantation (FMT), and the medication Ruxolitinib.
Plasmapheresis (from the Greek πλάσμα, plasma, something molded, and ἀφαίρεσις aphairesis, taking away) is the removal, treatment, and return or exchange of blood plasma or components thereof from and to the blood circulation. It is thus an extracorporeal therapy, a medical procedure performed outside the body. [1]